UT researcher: Interferon alpha can delay full onset of type I diabetes
Wednesday, July 1, 2009 - 17:49
in Health & Medicine
A low dose of oral interferon alpha shows promise in preserving beta cell function for patients with newly diagnosed type 1 diabetes, or juvenile diabetes, according to researchers at The University of Texas Medical School at Houston.